Nutritional Immunology Market Updates

Nutritional Immunology Market was valued at USD 62 Billion in 2023 and is poised to grow from USD 69.31 Billion in 2024 to USD 169.17 Billion by 2032, growing at a CAGR of 11.8% during the forecast period (2025-2032).

Key companies are primarily focusing on new product invention and development. For instance, in April 2019, Bayer AG developed a new approach on triple-action supplement to combat immunity issues during the Ramadan fasting period. Abbott released a new Pedialyte hydration product to enhance immunological health in December 2020. Pedialyte with Immune Support contains prebiotics, vitamin B12, vitamin C, vitamin E, and zinc, all of which have been specifically chosen for their role in immune system support. 'Chr. Hansen Holding A/S (Denmark) ', 'DuPont de Nemours, Inc. (USA) ', 'DSM (Netherlands) ', 'Lallemand Inc. (Canada) ', 'Yakult Honsha Co., Ltd. (Japan) ', 'Nestlé S.A. (Switzerland) ', 'Abbott Laboratories (USA) ', 'Pfizer Inc. (USA) ', 'Bayer AG (Germany) ', 'BASF SE (Germany) ', 'Nature's Way Products, LLC (USA) ', 'Gaia Herbs (USA) ', 'Indena S.p.A. (Italy) ', 'Sabinsa Corporation (USA) ', 'Fonterra Co-operative Group Limited (New Zealand) ', 'Arla Foods amba (Denmark) ', 'Amway (USA) ', 'Herbalife Nutrition Ltd. (USA) ', 'GNC Holdings, LLC (USA) ', 'USANA Health Sciences, Inc. (USA)'

For manufacturers, innovation has been a consistent component of the growth of the immune supplement market, as well as possibilities and corporate expansion. New product introductions that offer a variety of health advantages are driving greater demand for new immune supplement solutions. Furthermore, factors such as an increase in the use of conventional and new substances for supplement manufacture are driving the development of new revolutionary immune boosters. The elevated risk of infectious illnesses has also sparked interest in the creation of cutting-edge and novel immune health supplements.

The increasing frequency of chronic illnesses and other problems in senior individuals is likely to boost the worldwide immune health supplement market growth. Due to the rising incidence of chronic illnesses and other ailments among the senior population, the immune health supplements market is likely to increase significantly over the forecast period. According to a World Health Organization estimate from September 2019, around 50 million people worldwide have dementia, with nearly 10 million new cases diagnosed each year. According to the same source, Alzheimer's disease is the most prevalent kind of dementia, accounting for 60-70% of all cases.

North America led the market in 2021, accounting for the largest revenue share of 37.1%. The largest customer base for immune health supplements and rising individual awareness are expected to drive regional growth in the nutritional immunology market over the forecast years. Furthermore, a rising trend in the United States population to spend in preventative supplements is likely to boost market expansion in this region.